Fecal Microbiota Transfer 2.0
- PMID: 26908719
- PMCID: PMC4918822
- DOI: 10.1093/infdis/jiv768
Fecal Microbiota Transfer 2.0
Keywords: Clostridium difficile; Firmicute; fecal microbiome; metronidazol; microbiota transplant; randomized clinical trial; vancomycin.
Comment on
-
A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection.J Infect Dis. 2016 Jul 15;214(2):173-81. doi: 10.1093/infdis/jiv766. Epub 2016 Feb 8. J Infect Dis. 2016. PMID: 26908752
References
-
- van Nood E, Vrieze A, Nieuwdorp M et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013; 368:407–15. - PubMed
-
- Youngster I, Russell GH, Pindar C, Ziv-Baran T, Sauk J, Hohmann EL. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA 2014; 312:1772–8. - PubMed
-
- Khanna S, Pardi DS, Kelly CR et al. A novel microbiome therapeutic increases gut microbial diversity and prevents recurrent Clostridium difficile infection. J Infect Dis 2016; 214:174–81. - PubMed
-
- Sandhya P, Danda D, Sharma D, Scaria V. Does the buck stop with the bugs? an overview of microbial dysbiosis in rheumatoid arthritis. Int J Rheum Dis 2016; 19:8–20. - PubMed
-
- Alang N, Kelly CR. Weight gain after fecal microbiota transplantation. Open Forum Infect Dis 2015; doi:10.1093/ofid/ofv004. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical